NanJing Pharmaceutical Company Limited

Shanghai Stock Exchange 600713.SS

NanJing Pharmaceutical Company Limited Operating Cash Flow for the year ending December 31, 2023: USD 268.52 M

NanJing Pharmaceutical Company Limited Operating Cash Flow is USD 268.52 M for the year ending December 31, 2023, a 371.58% change year over year. Operating cash flow is cash generated from the company’s regular business operations.

NanJing Pharmaceutical Company Limited Operating Cash Flow for the year ending December 31, 2022 was USD -98.87 M, a -190.35% change year over year.
NanJing Pharmaceutical Company Limited Operating Cash Flow for the year ending December 31, 2021 was USD 109.43 M, a 161.98% change year over year.
NanJing Pharmaceutical Company Limited Operating Cash Flow for the year ending December 31, 2020 was USD -176.56 M, a -222.47% change year over year.
NanJing Pharmaceutical Company Limited Operating Cash Flow for the year ending December 31, 2019 was USD 144.17 M, a 370.24% change year over year.

Key data

Date	Operating Cash Flow	Net Cash Used For Investing Activities	Net Cash Used Provided By Financing Activities	Dividends Paid

Shanghai Stock Exchange: 600713.SS

NanJing Pharmaceutical Company Limited

CEO	Mr. Liang Zhang
IPO Date	July 1, 1996
Location	China
Headquarters	Building A
Employees	4,903
Sector	Health Care
Industries Drugstores & Retail Pharmacies Pharmaceuticals Retail & Wholesale

Description

NanJing Pharmaceutical Company Limited engages pharmaceutical wholesale and retail businesses in China. It also operates approximately 510 pharmacy retail stores and an e-commerce platform. The company was founded in 1951 and is based in Nanjing, China.

Key trends

Past 5 years